Capricor Therapeutics reported $3.38M in Loan Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Bioline Rx BLRX:US $ 1.66M 0.07M
Bluebird Bio BLUE:US $ 0M 0M
Capricor Therapeutics CAPR:US $ 3.38M 0M
Cytokinetics CYTK:US $ 197.08M 54.24M
Cytori Therapeutics CYTX:US $ 4.72M 287K
Geron GERN:US $ 50.18M 0.35M
Johnson & Johnson JNJ:US $ 28851M 1134M
Newlink Genetics NLNK:US $ 0M 0M
Prothena PRTA:US 0 0
Ptc Therapeutics PTCT:US $ 975.65M 0.99M
Sarepta Therapeutics SRPT:US $ 1098.85M 1.97M
Vascular Biogenics VBLT:US 0 0
Vital Therapies VTL:US $ 0M 0M